Use Able AI chat for product recommendations

PI3 Kinase p110 Beta Monoclonal antibody

PI3 Kinase p110 Beta Monoclonal Antibody for WB, IHC, IF/ICC, ELISA

Cat No. 67121-1-Ig
Clone No. 1B2A1
Publications (42)
Review Product
Download datasheet

Host / Isotype

Mouse / IgG1

Reactivity

human, rat and More (3)

Applications

WB, IHC, IF/ICC, IP, ELISA
For FC, select conjugated version.

PI3K p110(beta), PIK3CB, 1B2A1, EC:2.7.1.153, EC:2.7.11.1

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
PBS Only
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for PI3 Kinase p110 Beta in ?

Tested Applications

Positive WB detected inHEK-293 cells, HeLa cells, MCF-7 cells, SH-SY5Y cells, PC-12 cells
Positive IHC detected inhuman lung cancer tissue, human colon cancer tissue, human cervical cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:10000
Immunohistochemistry (IHC)IHC : 1:150-1:600
Immunofluorescence (IF)/ICCIF/ICC : 1:1000-1:4000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

67121-1-Ig targets PI3 Kinase p110 Beta in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, rat samples.

Tested Reactivity human, rat
Cited Reactivityhuman, mouse, rat, chicken, goat
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen

CatNo: Ag17505

Product name: Recombinant human PIK3CB protein

Source: e coli.-derived, PET28a

Tag: 6*His

Domain: 139-373 aa of BC114432

Sequence: SLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEV

Predict reactive species
Full Name phosphoinositide-3-kinase, catalytic, beta polypeptide
Calculated Molecular Weight 1070 aa, 123 kDa
Observed Molecular Weight 120-130 kDa
GenBank Accession NumberBC114432
Gene Symbol PI3 Kinase p110 Beta
Gene ID (NCBI) 5291
RRIDAB_2882424
Conjugate Unconjugated
FormLiquid
Purification MethodProtein G purification
UNIPROT IDP42338
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

PIK3CB(phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) is also named as PIK3C1, PI3K-beta, p110beta. The gene encodes a 1070 amino acid protein which belongs to the PI3/PI4-kinase family. Phosphoinositide 3-kinases (PI3Ks) have been implicated as participants in signaling pathways regulating cell growth by virtue of their activation in response to various mitogenic stimuli. The class I PI3 kinases are heterodimers composed of 110 kDa catalytic subunits that associate with regulatory adaptor proteins. Four class I catalytic subunits have been identified, PIK3CA (p110α), PIK3CB (p110β), PIK3CD (p110δ) and PIK3CG (p110γ)(PMID:19177002).

Protocols

Product Specific Protocols
IF protocol for PI3 Kinase p110 Beta antibody 67121-1-IgDownload protocol
IHC protocol for PI3 Kinase p110 Beta antibody 67121-1-IgDownload protocol
WB protocol for PI3 Kinase p110 Beta antibody 67121-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The PI3 Kinase p110 Beta Monoclonal antibody (catalog #67121-1-Ig) has 42 citations. These appear in journals including Cancer Discovery, Nature Metabolism, Biomaterials, Cancer Letters, Journal of Medicinal Chemistry, Cell Death Discovery, Journal of Translational Medicine, Frontiers in Oncology, Epigenomics, and Scientific Reports. Research fields span oncology (multiple cancer types and PI3K/AKT/mTOR signaling), metabolism, cardiovascular disease, neurology, inflammation, and traditional medicine mechanisms, primarily using Western blot, IHC, and IP applications.

SpeciesApplicationTitle
humanWB,IP,IF

Cancer Discov

PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis.

Authors - Shuang Tang
  • KD Validated
mouseWB

Nat Metab

Maternal exercise prevents metabolic disorders in offspring mice through SERPINA3C

Authors - Yang Li
ratWB

Biomaterials

Enhancing miR-19a/b induced cardiomyocyte proliferation in infarcted hearts by alleviating oxidant stress and controlling miR-19 release

Authors - Kai Wang

Cancer Lett

TRDMT1-mediated mRNA m(5)C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated DNA damage repair and IRS2 expression in pancreatic cancer.

Authors - Wenhao Luo
WB

Phytomedicine

Unveiling XinJia-LuHuang Granules' protective mechanism against atherosclerosis: Integrating network pharmacology, metabolomics, and experimental validation

Authors - Xueqian Liu
ratWB

Cell Death Discov

MFGE8 promotes adult hippocampal neurogenesis in rats following experimental subarachnoid hemorrhage via modifying the integrin β3/Akt signaling pathway

Authors - Zhen-Yan Li
Loading...
||
New chat

Able®

正在加载,请稍候...